EUVIMEDEUVIMED entdecken
EditorialOpen Access

AI in Oncology: Opportunity and Accountability

Beth Faiman

Journal of the Advanced Practitioner in Oncology · 11.05.2026 · 17 (3)

DOI: 10.6004/jadpro.2026.17.3.1 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of the Advanced Practitioner in Oncology, online erschienen am 11.05.2026. Verfasst von Beth Faiman. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, I presented a webinar for the Advanced Practitioner Society for Hematology and Oncology (APSHO) on the topic of artificial intelligence (AI) in cancer care, where I reviewed practical, ethical, and clinical applications. We discussed how advanced practitioners (APs) can use AI tools for clinical documentation, research, and scholarly communications. We discussed AI subcategories, including machine learning (ML), deep learning (DL), large language models (LLMs), and generative AI (GenAI), which are now common in medicine (Celik, 2025; Oermann et al., 2025).

Zitieren

APA

Faiman, B. (2026). AI in Oncology: Opportunity and Accountability. Journal of the Advanced Practitioner in Oncology, 17(3). https://doi.org/10.6004/jadpro.2026.17.3.1

Vancouver

Faiman B. AI in Oncology: Opportunity and Accountability. Journal of the Advanced Practitioner in Oncology. 2026;17(3). doi:10.6004/jadpro.2026.17.3.1

BibTeX
@article{Faiman2026,
  author = {Faiman, Beth},
  title = {AI in Oncology: Opportunity and Accountability},
  journal = {Journal of the Advanced Practitioner in Oncology},
  year = {2026},
  volume = {17},
  number = {3},
  doi = {10.6004/jadpro.2026.17.3.1}
}
Kostenlos starten →